MedPath

Propylthiouracil

PROPYLTHIOURACIL TABLETS, USP

Approved
Approval ID

53c5f586-3e72-479d-89ba-379683c8f6ba

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 26, 2023

Manufacturers
FDA

Chartwell RX, LLC

DUNS: 079394054

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Propylthiouracil

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code62135-606
Application NumberANDA080016
Product Classification
M
Marketing Category
C73584
G
Generic Name
Propylthiouracil
Product Specifications
Route of AdministrationORAL
Effective DateDecember 26, 2023
FDA Product Classification

INGREDIENTS (4)

PROPYLTHIOURACILActive
Quantity: 50 mg in 1 1
Code: 721M9407IY
Classification: ACTIB
CALCIUM STEARATEInactive
Code: 776XM7047L
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Propylthiouracil - FDA Drug Approval Details